Publication Details
Abstract
This study explores the ongoing development of penicillin antibiotics, which remain crucial for combating bacterial infections due to their low toxicity, broad distribution, and bactericidal properties. The emergence of penicillin-resistant Staphylococcus strains prompted the creation of methicillin and oxacillin, while aminopenicillins like ampicillin are now widely used against Gram-negative bacteria. Despite advances, the need for penicillins effective against Enterobacteriaceae remains a significant challenge. The research aimed to develop an ideal penicillin with high bioavailability, resistance to β-lactamases, strong bactericidal activity, low toxicity, and high affinity for penicillin-binding proteins. Results highlight progress in achieving these objectives, with implications for improving treatments against resistant bacterial strains.